Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03248479
Title Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination With Azacitidine in Patients With Hematological Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Forty Seven, Inc.
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Azacitidine + Hu5F9-G4

Hu5F9-G4

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.